phrykt

Moderna (MRNA) net income: −$2.8B

Moderna reported a net loss of −$2.8B for the year ended Dec 31, 2025.

From Moderna's filings with the SEC · Read the filing · MRNA stock page

Moderna net income by year

$12.2B2021$8.4B2022−$4.7B2023−$3.6B2024−$2.8B2025

#3,738 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025−$2.8B–
Dec 31, 2024−$3.6B–
Dec 31, 2023−$4.7B–
Dec 31, 2022$8.4B-31%
Dec 31, 2021$12.2B–

Net income of similar companies

Companies in the same industry as Moderna, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Vaxcyte−$767KDec 31, 2025
Twist Bioscience−$130MSep 30, 2026
Kodiak Sciences−$230MDec 31, 2025
Scholar Rock Holding−$378MDec 31, 2025
Immunovant−$506MMar 31, 2026
Revolution Medicines−$1.1BDec 31, 2025
Moderna−$2.8BDec 31, 2025

Questions and answers

What is Moderna's net income?

Moderna reported a net loss of −$2.8B for the year ended Dec 31, 2025.

Numbers as reported in Moderna's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology